Meanwhile, the diagnostic potency of tRF-17-18VBY9M was significantly better than that of traditional biomarkers, such as CEA, CA199, and CA724, which could effectively distinguish not only between GC patients and healthy donors but also between GC patients and gastritis patients. Here, CEACAM5 is linked to gastric cancer.